A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
6/5/2026
BreakingClinical TrialPharmaRetina
Oculis Scraps DME Eye Drop Program after Phase III Failure
Swiss company Oculis reported May 29 that it would not pursue US FDA approval for OCS-01, its dexamethasone eye drop candidate targeting diabetic macular edema (DME), after the primary endpoint of ...
6/5/2026
BreakingPharmaRegulationRetina
Outlook Therapeutics Resubmits BLA for Lytenava After Winning Appeal with FDA
Outlook Therapeutics reported June 1 that it had resubmitted its biologics license application (BLA) to the US FDA for Lytenava, its ophthalmic formulation of bevacizumab for the treatment of wet a...
6/5/2026
BreakingCataractEuropeSingle-UseSurgical
Rayner Launches New Ophteis Cohesive OVD, Rebrands Line
UK-based Rayner announced June 1 the launch of Ophteis Cohesive, a new ophthalmic viscosurgical device (OVD) developed and manufactured at its biomaterials facility in Portugal. The company said th...
6/5/2026
BreakingDealsLaserRetina
Zeiss, M2care Invest in Maculaser, Developer of Temperature-Controlled Retinal Laser Therapy
Finland-based Maculaser Oy has received a new investment from Zeiss Ventures, the corporate venture capital arm of Germany’s Zeiss Group, and M2care, a European health tech venture studio, as Macul...
6/5/2026
BreakingCataractDealsRefractiveSurgical
Sightpath to Deliver IQity’s Products Through Mobile Platform Under New Partnership
Reno, Nevada-based IQity reported May 21 that it was partnering with Sightpath Medical to deliver its technology to surgeons. IQity is developing eight products expected to launch between 2027 and ...
6/5/2026
AmblyopiaBreakingDeals
Luminopia Licenses Amblyopia Therapy to Rohto for Japan Market
Luminopia, of Cambridge, Massachusetts, reported June 2 that it had licensed its pediatric amblyopia treatmentto Rohto Pharmaceutical Co. to develop and commercialize in Japan. Rohto is a Japanese ...
6/5/2026
BreakingPharmaRegulation
US FDA Leadership Shakeup Continues as Drug Division Chief Exits
The US FDA’s drug evaluation division has another new leader. Michael Davis, MD, PhD, has been named acting director of the Center for Drug Evaluation and Research (CDER), according to the FDA’s we...
6/5/2026
BreakingFundingOptometry
Georgia Southern University Gains Funding for State’s First College of Optometry
Georgia Southern University announced May 26 that it had received $29.8 million in state funding to establish the first college of optometry in Georgia. The school said the money will support the r...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.